| http://www.w3.org/ns/prov#value | - Accordingly, the present invention provides compounds of Formula I, In Formula I, A is a MetAP-2 inhibitory core, W is O or NR2, and R1 and R2 are each, independently, hydrogen or alkyl; X is alkylene or substituted alkylene, preferably linear C1-C6-alkylene; n is 0 or 1; R3 and R4 are each, independently, hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted aryl or arylalkyl
|
